Latest On Conatus Pharmaceuticals Inc (CNAT):
About Conatus Pharmaceuticals Inc (CNAT):
Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines for the treatment of liver diseases in the United States. Its product candidate includes Emricasan, an orally active caspase protease inhibitor that is in Phase IIb clinical trials for post-orthotopic liver transplant as a result of hepatitis C virus infection with sustained viral response; for portal hypertension; for liver fibrosis caused by nonalcoholic steatohepatitis; and for liver function. The company is also developing CTS-2090, an orally active inhibitor of caspase 1, which is in preclinical development stage for treating chronic diseases involving inflammasome pathways. The company has a collaboration agreement with Novartis to conduct three Phase IIb clinical trials. Conatus Pharmaceuticals Inc. was founded in 2005 and is headquartered in San Diego, California.
General
- Name Conatus Pharmaceuticals Inc
- Symbol CNAT
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 5
- Fiscal Year EndDecember
- IPO Date2013-07-25
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.conatuspharma.com
Valuation
- Price/Sales (Trailing 12 Mt.) 1.26
- Price/Book (Most Recent Quarter) 1.05
- Enterprise Value Revenue 0.04
- Enterprise Value EBITDA 0.19
Financials
- Most Recent Quarter 2020-03-31
- Profit Margin -69%
- Operating Margin -73%
- Return on Assets -22%
- Return on Equity -49%
- Revenue 14.69 million
- Earnings Per Share -$0.44
- Revenue Per Share $0.44
- Gross Profit -1810000
- Quarterly Earnings Growth -92.9%
Highlights
- Market Capitalization 18.44 million
- EBITDA -14363000
- PEG Ratio -0.26
- Analyst Target Price $1.6
- Book Value Per Share $0.53
Share Statistics
- Shares Outstanding 33.17 million
- Shares Float 32.34 million
- % Held by Insiders 280%
- % Held by Institutions 13.92%
- Shares Short 130661
- Shares Short Prior Month 146024
- Short Ratio 0.37
Technicals
- Beta 1.84
- 52 Week High $7.2
- 52 Week Low $0.45
- 50 Day Moving Average 0.54
- 200 Day Moving Average 0.4
Dividends
- Dividend Date N/A
- ExDividend Date N/A
Conatus Pharmaceuticals Inc (CNAT) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Conatus Pharmaceuticals Inc (CNAT) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-03-31 | 2020-05-01 | $N/A | -$0.10 | ||
2019-12-31 | 2020-03-12 | $526000 | -$0.08 | ||
2019-09-30 | 2019-11-06 | $3.38 million | -$0.10 | -$0.12 | 16.67% |
2019-06-30 | 2019-08-07 | $10.79 million | -$0.02 | -$0.12 | 83.33% |
2019-03-31 | 2019-05-03 | $7.02 million | -$0.14 | -$0.12 | -16.67% |
2018-12-31 | 2019-03-11 | $7.41 million | -$0.13 | -$0.14 | 7.14% |
2018-09-30 | 2018-11-02 | $7.67 million | -$0.15 | -$0.15 | -1.33% |
2018-06-30 | 2018-08-02 | $8.77 million | -$0.15 | -$0.20 | 25.35% |
2018-03-31 | 2018-05-03 | $9.74 million | -$0.17 | -$0.17 | 1.76% |
2017-12-31 | 2018-03-08 | $8.81 million | -$0.15 | -$0.17 | 14.65% |
2017-09-30 | 2017-11-02 | $9.57 million | -$0.13 | -$0.05 | -166.6% |
2017-06-30 | 2017-08-03 | $10.01 million | -$0.19 | -$0.17 | -13.35% |
2017-03-31 | 2017-05-05 | $7 million | -$0.14 | ||
2016-12-31 | 2017-03-16 | $799000 | -$0.35 | -$0.26 | -35% |
2016-09-30 | 2016-11-09 | $N/A | -$0.31 | -$0.34 | 9.88% |
2016-06-30 | 2016-08-04 | $N/A | -$0.30 | -$0.38 | 20.95% |
2016-03-31 | 2016-05-05 | $N/A | -$0.35 | ||
2015-12-31 | 2016-03-10 | $N/A | -$0.30 | ||
2015-09-30 | 2015-11-05 | $N/A | -$0.31 | ||
2015-06-30 | 2015-08-06 | $N/A | -$0.31 | ||
2015-03-31 | 2015-05-08 | $N/A | -$0.38 | ||
2014-12-31 | 2015-03-12 | $N/A | -$0.34 | ||
2014-09-30 | 2014-11-13 | $N/A | -$0.42 | ||
2014-06-30 | 2014-08-14 | $N/A | -$0.34 | ||
2014-03-31 | 2014-05-14 | $N/A | -$0.34 | ||
2013-12-31 | 2014-03-28 | $N/A | -$0.37 | ||
2013-09-30 | 2013-11-15 | $N/A | -$0.28 | ||
2013-06-30 | 2013-09-10 | $N/A | $0.16 |
Conatus Pharmaceuticals Inc (CNAT) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 |
---|---|---|---|---|---|
Research Development | N/A | 23.53 million | 4.75 million | 8.57 million | 8.57 million |
Income Before Tax | N/A | -2.73 million | -3.25 million | -656000 | -4.75 million |
Selling General Administrative | N/A | 2.54 million | 2.01 million | 3.05 million | 2.59 million |
Gross Profit | N/A | 23.22 million | 3.38 million | 2.23 million | -2.36 million |
Ebit | N/A | -2.85 million | -3.38 million | -828000 | -4.95 million |
Operating Income | N/A | -2.85 million | -3.38 million | -828000 | -4.95 million |
Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
Total Revenue | N/A | 526000 | 3.38 million | 10.79 million | 7.02 million |
Cost of Revenue | N/A | -22.69 million | N/A | 8.57 million | 9.38 million |
Total Other Income Expense Net | N/A | 116000 | 130000 | 172000 | 203000 |
Net Income From Continuing Operations | N/A | -2.73 million | -3.25 million | -656000 | -4.75 million |
Net Income Applicable to Common Shares | -3.48 million | -2.73 million | -3.25 million | -656000 | -4.75 million |
Cash Flow:
Date | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 |
---|---|---|---|---|---|
Investments | N/A | 4.37 million | 10.98 million | -577000 | 14.58 million |
Change to Liabilities | -399000 | -2.35 million | -4.58 million | -6.28 million | -2.03 million |
Total Cash Flow from Investing Activities | N/A | 4.37 million | 10.98 million | -579000 | 14.57 million |
Net Borrowings | N/A | N/A | N/A | N/A | N/A |
Total Cash Flow from Financial Activities | N/A | -1000 | N/A | 4000 | 4000 |
Change to Operating Activities | 168000 | 393000 | -944000 | -3000 | -855000 |
Change in Cash | N/A | 2.39 million | 4.88 million | -5.73 million | 7.6 million |
Total Cash from Operating Activities | -2.65 million | -1.98 million | -6.1 million | -5.16 million | -6.96 million |
Depreciation | N/A | 11000 | 21000 | 21000 | 20000 |
Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
Change to Inventory | N/A | N/A | N/A | N/A | N/A |
Change to Account Receivables | N/A | 1.53 million | 1.54 million | 666000 | -183000 |
Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
Change to Net Income | 936000 | 1.17 million | 1.12 million | 1.09 million | 832000 |
Capital Expenditures | N/A | N/A | N/A | 2000 | 9000 |
Balance Sheet:
Date | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 |
---|---|---|---|---|---|
Total Liabailities | N/A | 1.64 million | 4.16 million | 12.06 million | 18.58 million |
Total Stockholder Equity | N/A | 20.19 million | 22 million | 24.11 million | 23.6 million |
Other Current Liabilities | N/A | N/A | 404000 | 2.13 million | 8.15 million |
Total Assets | N/A | 21.83 million | 26.16 million | 36.17 million | 42.18 million |
Common Stock | 3000 | 3000 | 3000 | 3000 | 3000 |
Other Current Assets | N/A | N/A | N/A | 6.66 million | 6.49 million |
Retained Earnings | -201.5 million | -198.01 million | -195.29 million | -192.03 million | -191.38 million |
Other Liabilities | N/A | N/A | N/A | 116000 | 1.58 million |
Other Assets | 147000 | 221000 | 550000 | 195000 | 1.19 million |
Cash | N/A | 20.7 million | 18.31 million | 13.44 million | 19.17 million |
Total Current Liabilities | N/A | 1.64 million | 4.16 million | 11.94 million | 16.78 million |
Other Stockholder Equity | N/A | N/A | 1000 | 5000 | 3000 |
Property, Plant & Equipment | N/A | N/A | 102000 | 560000 | 659000 |
Total Current Assets | N/A | 21.61 million | 25.51 million | 35.41 million | 40.33 million |
Long Term Investments | N/A | N/A | N/A | N/A | N/A |
Net Tangible Assets | 17.64 million | 20.19 million | 22 million | 24.11 million | 23.6 million |
Short Term Investments | N/A | N/A | 4.37 million | 15.31 million | 14.67 million |
Long Term Debt | N/A | N/A | N/A | N/A | 229000 |
Inventory | N/A | N/A | N/A | N/A | N/A |
Accounts Payable | N/A | 1.06 million | 3.01 million | 8.61 million | 7.29 million |
Conatus Pharmaceuticals Inc (CNAT) Chart:
Conatus Pharmaceuticals Inc (CNAT) News:
Below you will find a list of latest news for Conatus Pharmaceuticals Inc (CNAT) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Conatus Pharmaceuticals Inc (CNAT) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Conatus Pharmaceuticals Inc (CNAT) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-26 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1383701/000119312520181139/0001193125-20-181139-index.htm |
2020-03-06 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1383701/000000000020002058/0000000000-20-002058-index.htm |
2020-08-24 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1383701/000000000020007877/0000000000-20-007877-index.htm |
2018-02-01 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1383701/000021545718004566/0000215457-18-004566-index.htm |
2018-07-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1383701/000021545718005869/0000215457-18-005869-index.htm |
2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1383701/000021545719006713/0000215457-19-006713-index.htm |
2019-04-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1383701/000021545719007712/0000215457-19-007712-index.htm |
2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014288/0000899243-20-014288-index.htm |
2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014290/0000899243-20-014290-index.htm |
2020-05-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014293/0000899243-20-014293-index.htm |
2020-05-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014451/0000899243-20-014451-index.htm |
2020-05-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014452/0000899243-20-014452-index.htm |
2020-05-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014454/0000899243-20-014454-index.htm |
2020-05-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014456/0000899243-20-014456-index.htm |
2020-05-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014459/0000899243-20-014459-index.htm |
2020-05-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014462/0000899243-20-014462-index.htm |
2020-05-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014463/0000899243-20-014463-index.htm |
2020-05-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014464/0000899243-20-014464-index.htm |
2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014468/0000899243-20-014468-index.htm |
2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014470/0000899243-20-014470-index.htm |
2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014471/0000899243-20-014471-index.htm |
2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014472/0000899243-20-014472-index.htm |
2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014475/0000899243-20-014475-index.htm |
2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014477/0000899243-20-014477-index.htm |
2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014479/0000899243-20-014479-index.htm |
2020-05-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014480/0000899243-20-014480-index.htm |
2020-05-29 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014545/0000899243-20-014545-index.htm |
2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014546/0000899243-20-014546-index.htm |
2017-09-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184317005351/0001171843-17-005351-index.htm |
2017-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184317006486/0001171843-17-006486-index.htm |
2018-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184318000882/0001171843-18-000882-index.htm |
2018-03-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184318001755/0001171843-18-001755-index.htm |
2018-04-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184318002527/0001171843-18-002527-index.htm |
2018-05-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184318003332/0001171843-18-003332-index.htm |
2018-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184318004815/0001171843-18-004815-index.htm |
2018-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184318005617/0001171843-18-005617-index.htm |
2018-09-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184318006531/0001171843-18-006531-index.htm |
2018-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184318007474/0001171843-18-007474-index.htm |
2018-12-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184318008331/0001171843-18-008331-index.htm |
2018-12-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184318008332/0001171843-18-008332-index.htm |
2019-03-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184319001602/0001171843-19-001602-index.htm |
2019-03-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184319001889/0001171843-19-001889-index.htm |
2019-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184319002190/0001171843-19-002190-index.htm |
2019-05-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184319002867/0001171843-19-002867-index.htm |
2019-05-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184319003741/0001171843-19-003741-index.htm |
2019-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184319004145/0001171843-19-004145-index.htm |
2019-07-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184319004288/0001171843-19-004288-index.htm |
2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184319005210/0001171843-19-005210-index.htm |
2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184319007181/0001171843-19-007181-index.htm |
2019-11-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184319007632/0001171843-19-007632-index.htm |
2019-12-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184319008300/0001171843-19-008300-index.htm |
2020-03-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184320001652/0001171843-20-001652-index.htm |
2020-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000117184320003170/0001171843-20-003170-index.htm |
2020-05-01 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1383701/000117184320003171/0001171843-20-003171-index.htm |
2017-11-08 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1383701/000119312517337229/0001193125-17-337229-index.htm |
2018-02-06 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1383701/000119312518033096/0001193125-18-033096-index.htm |
2018-03-09 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1383701/000119312518077337/0001193125-18-077337-index.htm |
2018-04-27 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1383701/000119312518139072/0001193125-18-139072-index.htm |
2018-08-02 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1383701/000119312518236596/0001193125-18-236596-index.htm |
2019-04-30 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1383701/000119312519126925/0001193125-19-126925-index.htm |
2019-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000119312519147983/0001193125-19-147983-index.htm |
2019-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000119312519209639/0001193125-19-209639-index.htm |
2019-09-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000119312519253568/0001193125-19-253568-index.htm |
2019-10-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000119312519262731/0001193125-19-262731-index.htm |
2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000119312519287314/0001193125-19-287314-index.htm |
2019-11-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000119312519302624/0001193125-19-302624-index.htm |
2020-01-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000119312520016930/0001193125-20-016930-index.htm |
2020-01-28 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1383701/000119312520016931/0001193125-20-016931-index.htm |
2020-01-28 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1383701/000119312520017114/0001193125-20-017114-index.htm |
2020-01-30 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1383701/000119312520019095/0001193125-20-019095-index.htm |
2020-01-30 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1383701/000119312520019101/0001193125-20-019101-index.htm |
2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1383701/000119312520025220/0001193125-20-025220-index.htm |
2020-02-06 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1383701/000119312520026229/0001193125-20-026229-index.htm |
2020-02-07 | S-4 | Registration of securities, business combinations | https://www.sec.gov/Archives/edgar/data/1383701/000119312520028298/0001193125-20-028298-index.htm |
2020-03-13 | S-4/A | Registration of securities, business combinations | https://www.sec.gov/Archives/edgar/data/1383701/000119312520073055/0001193125-20-073055-index.htm |
2020-03-13 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1383701/000119312520073097/0001193125-20-073097-index.htm |
2020-03-30 | S-4/A | Registration of securities, business combinations | https://www.sec.gov/Archives/edgar/data/1383701/000119312520091055/0001193125-20-091055-index.htm |
2020-03-30 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1383701/000119312520091070/0001193125-20-091070-index.htm |
2020-04-01 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1383701/000119312520094708/0001193125-20-094708-index.htm |
2020-04-06 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1383701/000119312520098969/0001193125-20-098969-index.htm |
2020-04-15 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1383701/000119312520107673/0001193125-20-107673-index.htm |
2020-04-20 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1383701/000119312520111604/0001193125-20-111604-index.htm |
2020-04-22 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1383701/000119312520115040/0001193125-20-115040-index.htm |
2020-05-01 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1383701/000119312520129812/0001193125-20-129812-index.htm |
2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000119312520136238/0001193125-20-136238-index.htm |
2020-05-07 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1383701/000119312520136240/0001193125-20-136240-index.htm |
2020-05-11 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1383701/000119312520138321/0001193125-20-138321-index.htm |
2020-05-11 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1383701/000119312520139036/0001193125-20-139036-index.htm |
2020-05-14 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1383701/000119312520142782/0001193125-20-142782-index.htm |
2020-05-18 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1383701/000119312520145029/0001193125-20-145029-index.htm |
2020-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000119312520148679/0001193125-20-148679-index.htm |
2020-05-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000119312520152366/0001193125-20-152366-index.htm |
2020-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000119312520153827/0001193125-20-153827-index.htm |
2020-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000119312520156548/0001193125-20-156548-index.htm |
2020-06-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000119312520162163/0001193125-20-162163-index.htm |
2020-06-26 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000119312520181137/0001193125-20-181137-index.htm |
2020-06-26 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1383701/000119312520181139/0001193125-20-181139-index.htm |
2020-07-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1383701/000119312520195506/0001193125-20-195506-index.htm |
2020-07-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000119312520195522/0001193125-20-195522-index.htm |
2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000119312520213704/0001193125-20-213704-index.htm |
2020-08-17 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1383701/000119312520222488/0001193125-20-222488-index.htm |
2020-08-24 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1383701/000119312520228320/0001193125-20-228320-index.htm |
2020-08-27 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1383701/000119312520233284/0001193125-20-233284-index.htm |
2020-08-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000119312520233288/0001193125-20-233288-index.htm |
2020-09-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000119312520257231/0001193125-20-257231-index.htm |
2017-09-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919117051050/0001209191-17-051050-index.htm |
2017-09-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919117051052/0001209191-17-051052-index.htm |
2018-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919118007553/0001209191-18-007553-index.htm |
2018-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919118007556/0001209191-18-007556-index.htm |
2018-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919118007558/0001209191-18-007558-index.htm |
2018-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919118007561/0001209191-18-007561-index.htm |
2018-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919118007562/0001209191-18-007562-index.htm |
2018-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919118007563/0001209191-18-007563-index.htm |
2018-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919118007564/0001209191-18-007564-index.htm |
2018-02-05 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919118007565/0001209191-18-007565-index.htm |
2018-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919118014949/0001209191-18-014949-index.htm |
2018-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919118028454/0001209191-18-028454-index.htm |
2018-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919118039395/0001209191-18-039395-index.htm |
2018-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919118039396/0001209191-18-039396-index.htm |
2018-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919118039397/0001209191-18-039397-index.htm |
2018-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919118039398/0001209191-18-039398-index.htm |
2018-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919118039399/0001209191-18-039399-index.htm |
2018-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919118039400/0001209191-18-039400-index.htm |
2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919119008917/0001209191-19-008917-index.htm |
2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919119008920/0001209191-19-008920-index.htm |
2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919119008922/0001209191-19-008922-index.htm |
2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919119008924/0001209191-19-008924-index.htm |
2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919119008925/0001209191-19-008925-index.htm |
2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919119008929/0001209191-19-008929-index.htm |
2019-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919119008930/0001209191-19-008930-index.htm |
2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919119039725/0001209191-19-039725-index.htm |
2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919119039729/0001209191-19-039729-index.htm |
2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919119039731/0001209191-19-039731-index.htm |
2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919119039732/0001209191-19-039732-index.htm |
2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919119039734/0001209191-19-039734-index.htm |
2019-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919119044008/0001209191-19-044008-index.htm |
2019-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919119044011/0001209191-19-044011-index.htm |
2019-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919119044012/0001209191-19-044012-index.htm |
2019-08-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919119044014/0001209191-19-044014-index.htm |
2019-11-19 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919119057122/0001209191-19-057122-index.htm |
2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919119057129/0001209191-19-057129-index.htm |
2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919120054432/0001209191-20-054432-index.htm |
2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919120054434/0001209191-20-054434-index.htm |
2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919120054435/0001209191-20-054435-index.htm |
2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919120054436/0001209191-20-054436-index.htm |
2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919120054437/0001209191-20-054437-index.htm |
2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919120054441/0001209191-20-054441-index.htm |
2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919120054445/0001209191-20-054445-index.htm |
2020-10-19 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919120055258/0001209191-20-055258-index.htm |
2020-10-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1383701/000120919120055262/0001209191-20-055262-index.htm |
2017-11-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1383701/000156459017021246/0001564590-17-021246-index.htm |
2018-03-08 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1383701/000156459018004914/0001564590-18-004914-index.htm |
2018-05-03 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1383701/000156459018010665/0001564590-18-010665-index.htm |
2018-08-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1383701/000156459018018892/0001564590-18-018892-index.htm |
2018-11-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1383701/000156459018026299/0001564590-18-026299-index.htm |
2019-03-08 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1383701/000156459019007030/0001564590-19-007030-index.htm |
2019-05-03 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1383701/000156459019015689/0001564590-19-015689-index.htm |
2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1383701/000156459019030048/0001564590-19-030048-index.htm |
2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1383701/000156459019040404/0001564590-19-040404-index.htm |
2020-03-11 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1383701/000156459020010122/0001564590-20-010122-index.htm |
2020-03-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000156459020014191/0001564590-20-014191-index.htm |
2020-05-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1383701/000156459020020517/0001564590-20-020517-index.htm |
2020-08-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1383701/000156459020040018/0001564590-20-040018-index.htm |
2020-08-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1383701/000156459020040035/0001564590-20-040035-index.htm |
2017-11-09 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1383701/999999999517002939/9999999995-17-002939-index.htm |
2020-04-01 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1383701/999999999520000660/9999999995-20-000660-index.htm |
2020-08-26 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1383701/999999999520002269/9999999995-20-002269-index.htm |
2020-07-31 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1383701/999999999720004234/9999999997-20-004234-index.htm |
Conatus Pharmaceuticals Inc (CNAT) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Conatus Pharmaceuticals Inc (CNAT). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 280%Institutional Ownership: 1392%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2018-11-14 | Edward F III Smith | SVP, Reg Affairs and QA | Buy | 1,724.00 | 3.15 | 5,430.60 | 10,875.00 | https://www.sec.gov/Archives/edgar/data/1383701/000120919119008925/0001209191-19-008925-index.htm |
2018-02-27 | Alfred P. Spada | EVP, R&D and CSO | Buy | 12,121.00 | 1.24 | 15,030.04 | 12,121.00 | https://www.sec.gov/Archives/edgar/data/1383701/000120919118014949/0001209191-18-014949-index.htm |
2017-05-12 | DANIEL L. RIPLEY | SVP, Bus Dev, P&A Mgmt | Buy | 761.00 | 1.70 | 1,293.70 | 28,462.00 | https://www.sec.gov/Archives/edgar/data/1383701/000120919118007561/0001209191-18-007561-index.htm |
2017-11-14 | DANIEL L. RIPLEY | SVP, Bus Dev, P&A Mgmt | Buy | 818.00 | 3.48 | 2,846.64 | 29,280.00 | https://www.sec.gov/Archives/edgar/data/1383701/000120919118007561/0001209191-18-007561-index.htm |
2018-05-14 | DANIEL L. RIPLEY | SVP, Bus Dev, P&A Mgmt | Buy | 1,290.00 | 3.31 | 4,269.90 | 30,570.00 | https://www.sec.gov/Archives/edgar/data/1383701/000120919119008924/0001209191-19-008924-index.htm |
2018-11-14 | DANIEL L. RIPLEY | SVP, Bus Dev, P&A Mgmt | Buy | 1,861.00 | 3.15 | 5,862.15 | 32,431.00 | https://www.sec.gov/Archives/edgar/data/1383701/000120919119008924/0001209191-19-008924-index.htm |
2020-05-22 | Alfred P. Spada | EVP, R&D and CSO | Buy | 31,343.00 | 32,555.00 | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014290/0000899243-20-014290-index.htm | ||
2020-05-22 | Keith W Marshall | EVP, COO & CFO | Buy | 38,500.00 | 38,500.00 | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014293/0000899243-20-014293-index.htm | ||
2017-11-14 | Edward F III Smith | SVP, Reg Affairs and QA | Buy | 4,461.00 | 3.48 | 15,524.28 | 4,461.00 | https://www.sec.gov/Archives/edgar/data/1383701/000120919118007562/0001209191-18-007562-index.htm |
2018-05-04 | Steven J Mento | President, CEO & Director | Buy | 60,000.00 | 0.99 | 59,400.00 | 60,000.00 | https://www.sec.gov/Archives/edgar/data/1383701/000120919118028454/0001209191-18-028454-index.htm |
2020-05-22 | Steven J Mento | Director | Buy | 65,000.00 | 71,000.00 | https://www.sec.gov/Archives/edgar/data/1383701/000089924320014288/0000899243-20-014288-index.htm | ||
2018-05-14 | Edward F III Smith | SVP, Reg Affairs and QA | Buy | 4,690.00 | 3.31 | 15,523.90 | 9,151.00 | https://www.sec.gov/Archives/edgar/data/1383701/000120919119008925/0001209191-19-008925-index.htm |